TWAPF (TOWA Pharmaceutical Co) Total Stockholders Equity: $1,122 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TWAPF TOWA Pharmaceutical Co Ltd TWAPF
67 GF Score
Price $25.98
GF Value $14.22
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is TOWA Pharmaceutical Co Total Stockholders Equity?

TOWA Pharmaceutical Co TWAPF 67 Total Stockholders Equity is $1,122 Mil as of Mar. 2026. GuruFocus rates TWAPF with a GF Score™ of 67/100 and a GF Value™ of $14.22 (Significantly Overvalued). The stock has 7 warning signs investors should review.

TOWA Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $1,122 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. TOWA Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2026 was $22.80. The ratio of a company's debt over equity can be used to measure how leveraged this company is. TOWA Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2026 was 1.27.

TOWA Pharmaceutical Co  (OTCPK:TWAPF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

TOWA Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1122.384-0)/49.228
=22.80

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

TOWA Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(192.655 + 1236.203) / 1122.384
=1.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TOWA Pharmaceutical Co Total Stockholders Equity Related Terms

TOWA Pharmaceutical Co Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for TOWA Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TOWA Pharmaceutical Co Total Stockholders Equity Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,114.61 1,024.16 1,040.54 1,151.39 1,122.38

TOWA Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,151.39 1,195.43 1,216.41 1,216.62 1,122.38
TWAPF
67GF Score
TOWA Pharmaceutical Co Ltd TWAPF
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $1,122 Mil mean?
TOWA Pharmaceutical Co (TWAPF) has a Total Stockholders Equity of $1,122 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for TOWA Pharmaceutical Co and its competitors.
Is TOWA Pharmaceutical Co's Total Stockholders Equity too high?
TOWA Pharmaceutical Co's current Total Stockholders Equity is $1,122 Mil. Overall, TOWA Pharmaceutical Co has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's Total Stockholders Equity compare to ZTS?
TOWA Pharmaceutical Co's Total Stockholders Equity of $1,122 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for TOWA Pharmaceutical Co and its competitors. TOWA Pharmaceutical Co's current Total Stockholders Equity is $1,122 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, TOWA Pharmaceutical Co (TWAPF) is currently considered Significantly Overvalued. The stock's GF Value™ is $14.22, compared to a current price of $25.98 — trading 82.7% above its estimated fair value. The current Total Stockholders Equity is $1,122 Mil. TOWA Pharmaceutical Co's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For TOWA Pharmaceutical Co (TWAPF), the current Total Stockholders Equity is $1,122 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TOWA Pharmaceutical Co (TWAPF) Overvalued in 2026?

Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued. The current stock price of $25.98 is trading 82.7% above its estimated GF Value™ of $14.22. GuruFocus considers TOWA Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for TWAPF:

  • Total Stockholders Equity: $1,122 Mil
  • GF Value™: $14.22 vs. price of $25.98 (82.7% above fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the TWAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TOWA Pharmaceutical Co Business Description

Other Exchanges 4553:Japan6QC:Germany
Address 2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
67GF Score

Get the complete analysis for TWAPF

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.98
Price
$14.22
GF Value